- Home
- Programs and Groups
- Shared Resources
- Faculty
- Clinical Trials
- Tumor Registry
- Education
- About DCI
Quick Links
Breadcrumbs Navigation
Home > Clinical Trials > NANT2007-02 A Phase I Study of Bevacizumab with Bolus and Metronomic Cyclophosphamide and Zoledronic Acid in Children with Recurrent or Refractory NeuroblastomaNANT2007-02 A Phase I Study of Bevacizumab with Bolus and Metronomic Cyclophosphamide and Zoledronic Acid in Children with Recurrent or Refractory Neuroblastoma
Category: Pediatric Phase I/II (new anti-cancer drugs) (Pediatric)
Phase: Phase I
Principal Investigator: Susan Kreissman
Phone: 919-684-3401
Sponsor: Cooperative Group Initiated
ID Number: 00028882
NCT Number: NCT00885326
